BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.63 USD -0.13% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
BioCryst Pharmaceuticals Inc?
Write Note

BioCryst Pharmaceuticals Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioCryst Pharmaceuticals Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Gross Profit
$404.6m
CAGR 3-Years
56%
CAGR 5-Years
109%
CAGR 10-Years
36%
Abbvie Inc
NYSE:ABBV
Gross Profit
$37.3B
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
9%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$22B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.7B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$9.2B
CAGR 3-Years
13%
CAGR 5-Years
24%
CAGR 10-Years
29%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$12B
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
17%

See Also

What is BioCryst Pharmaceuticals Inc's Gross Profit?
Gross Profit
404.6m USD

Based on the financial report for Sep 30, 2024, BioCryst Pharmaceuticals Inc's Gross Profit amounts to 404.6m USD.

What is BioCryst Pharmaceuticals Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
36%

Over the last year, the Gross Profit growth was 30%. The average annual Gross Profit growth rates for BioCryst Pharmaceuticals Inc have been 56% over the past three years , 109% over the past five years , and 36% over the past ten years .

Back to Top